Generative Artificial Intelligence in Healthcare
A Global Strategic Business Report
MCP31170
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETINGHIGHLIGHTS & REPORT INDEX
Global Generative Artificial Intelligence in Healthcare Market to Reach US$17.0 Billion by 2030
The global market for Generative Artificial Intelligence in Healthcare estimated at US$2.7 Billion in the year 2024, is expected to reach US$17.0 Billion by 2030, growing at a CAGR of 36.0% over the analysis period 2024-2030. Solutions Component, one of the segments analyzed in the report, is expected to record a 34.6% CAGR and reach US$9.7 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 38.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$704.4 Million While China is Forecast to Grow at 34.3% CAGR
The Generative Artificial Intelligence in Healthcare market in the U.S. is estimated at US$704.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 34.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.7% and 31.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 25.3% CAGR.
Global Generative Artificial Intelligence in Healthcare Market – Key Trends & Drivers Summarized
What Are the Transformative Capabilities of Generative AI in Healthcare?
Generative Artificial Intelligence is reshaping healthcare by leveraging its ability to analyze complex datasets and generate predictive models, enabling breakthroughs in diagnostics, treatment, and patient care. By harnessing vast volumes of patient data, medical records, and imaging scans, AI algorithms can deliver precise and timely insights that significantly enhance clinical outcomes. Generative AI`s ability to create new data from existing patterns is particularly valuable in imaging diagnostics, where it identifies diseases such as cancer, heart conditions, and neurological disorders with unparalleled accuracy. Beyond diagnostics, the technology aids in modeling complex biological systems, allowing for the simulation of disease progression and treatment efficacy in silico, reducing the reliance on costly and time-intensive physical experiments. Personalized medicine has emerged as a flagship application of generative AI. By tailoring treatments to individual patients` genetic and lifestyle profiles, AI ensures optimized care with minimal adverse effects. Furthermore, the technology supports medical education and training by simulating rare and complex medical conditions, empowering clinicians to refine their skills in controlled environments. These transformative capabilities of generative AI have established it as a cornerstone of the future of healthcare delivery.
Why Is the Pharmaceutical Sector at the Forefront of Generative AI Adoption?
The pharmaceutical industry is experiencing a paradigm shift as generative AI accelerates drug discovery and development. This technology significantly reduces the traditionally prohibitive time and cost associated with bringing new drugs to market. AI-driven platforms identify promising molecular compounds, simulate their interactions, and predict pharmacological properties, streamlining the preclinical phase. By facilitating virtual drug trials and computational predictions, generative AI minimizes the likelihood of late-stage failures, ensuring higher success rates and faster approval processes. AI`s role in drug repurposing has also proven to be a game-changer. By analyzing existing datasets and exploring new applications for established drugs, pharmaceutical companies can address unmet medical needs more efficiently. Furthermore, generative AI enhances clinical trial management by selecting optimal patient cohorts, ensuring adherence to study protocols, and analyzing real-time data to identify anomalies. These innovations not only improve the speed and accuracy of drug development but also contribute to cost-effectiveness, fostering more robust pipelines for critical therapies.
How Are Healthcare Providers Integrating Generative AI Into Operations?
Hospitals and healthcare providers are embracing generative AI to improve operational efficiency, patient care, and resource utilization. AI-powered systems are revolutionizing administrative workflows, from appointment scheduling and billing to data management and compliance monitoring, allowing healthcare staff to focus on direct patient interactions. Integrating AI with electronic health records (EHRs) ensures that clinicians have access to accurate, up-to-date information, enabling faster and more informed decision-making. Telemedicine has witnessed exponential growth, driven in part by AI-enabled virtual assistants and diagnostic tools. These platforms enhance the quality of remote consultations by offering real-time insights and monitoring capabilities, particularly in underserved and rural areas. Additionally, predictive analytics powered by AI supports hospitals in resource planning by forecasting patient admission trends and optimizing staff deployment. Robotic-assisted surgeries, guided by generative AI, are setting new benchmarks for precision and reducing recovery times. Together, these advancements reflect the growing integration of AI into healthcare ecosystems, ensuring improved outcomes for providers and patients alike.
What Factors Are Driving the Growth of the Generative AI in Healthcare Market?
The growth of the Generative Artificial Intelligence in Healthcare market is driven by several key factors, including the increasing volume of healthcare data, advancements in computational power, and the rising demand for personalized care. The adoption of AI by pharmaceutical companies has been a major catalyst, enabling faster drug discovery and reducing costs. Moreover, the expansion of telehealth services and remote care solutions has fueled demand for AI-powered platforms that facilitate seamless and efficient patient management, particularly in areas with limited healthcare access. Consumer expectations for precision medicine and tailored treatments have pushed healthcare providers to adopt generative AI tools that enhance patient satisfaction and clinical outcomes. Insurers are also turning to AI for fraud detection, risk assessment, and personalized policy creation, broadening the technology`s application across the healthcare landscape. Additionally, governments and private entities are making significant investments in AI research and innovation, with regulatory bodies adapting to ensure ethical deployment and interoperability. These factors collectively underscore the transformative impact of generative AI on the healthcare sector and its role in shaping the future of global health systems.
SCOPE OF STUDY
The report analyzes the Generative Artificial Intelligence in Healthcare market by the following Segments, and Geographic Regions/Countries:
Segments:
Component (Solutions Component, Services Component); Function (Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function, Administrative Process Optimization Function); Application (Clinical Application, System Application); End-Use (Clinical Research End-Use, Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
Amazon Web Services, Inc.; Deloitte; ELEKS; Google Cloud; IBM Corporation; Insilico Medicine; LeewayHertz ; Microsoft Corporation; Nioyatech LLC; NVIDIA Corporation
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Economic Frontiers: Trends, Trials & Transformations |
| Generative Artificial Intelligence in Healthcare – Global Key Competitors Percentage Market Share in 2024 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 27 Players Worldwide in 2024 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Generative AI Spurs Growth in Diagnostics and Personalized Healthcare Solutions |
| Expansion of Predictive Analytics Tools Broadens Addressable Market in Patient Care |
| Increased Demand for Virtual Health Assistants Drives AI Adoption in Telemedicine |
| Generative AI Revolutionizes Drug Discovery and Accelerates Development Timelines |
| Automation of Administrative Workflows Strengthens the Business Case for AI in Healthcare |
| AI-Driven Advances in Medical Imaging Propel Growth in Radiology Applications |
| IoMT Integration Sustains Growth Opportunities for AI in Connected Healthcare Systems |
| AI-Powered Clinical Decision Support Systems Propel Adoption Across Healthcare Facilities |
| Generative AI Addresses Workforce Shortages by Optimizing Healthcare Delivery |
| AI Innovations Enhance Market Potential for Mental Health Solutions |
| AI-Based Simulation Tools Drive Adoption in Medical Training and Education Programs |
| Precision Oncology Gains Momentum with Generative AI-Enabled Targeted Therapies |
| Data Privacy and Security Challenges Influence Market Dynamics and Adoption Rates |
| AI-Enhanced Patient Engagement Models Create New Opportunities in Care Delivery |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Generative Artificial Intelligence in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Solutions Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Medical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Medical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Clinical Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Clinical Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Medical Imaging Analysis Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Medical Imaging Analysis Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Virtual Nursing Assistants Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Virtual Nursing Assistants Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Robot-Assisted AI Surgery Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Robot-Assisted AI Surgery Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Administrative Process Optimization Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Administrative Process Optimization Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Clinical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Clinical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for System Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| JAPAN |
| Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| CHINA |
| Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| EUROPE |
| Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| FRANCE |
| Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| GERMANY |
| Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| UNITED KINGDOM |
| Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| ASIA-PACIFIC |
| Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]